• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies

tetano

Editor, Senior Moderator
Cell


. 2021 May 4;S0092-8674(21)00580-8.
doi: 10.1016/j.cell.2021.04.045. Online ahead of print.
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies


Meghan E Garrett[SUP] 1 [/SUP], Jared Galloway[SUP] 2 [/SUP], Helen Y Chu[SUP] 3 [/SUP], Hannah L Itell[SUP] 1 [/SUP], Caitlin I Stoddard[SUP] 4 [/SUP], Caitlin R Wolf[SUP] 3 [/SUP], Jennifer K Logue[SUP] 3 [/SUP], Dylan McDonald[SUP] 3 [/SUP], Haidyn Weight[SUP] 4 [/SUP], Frederick A Matsen 4th[SUP] 5 [/SUP], Julie Overbaugh[SUP] 6 [/SUP]



Affiliations

Abstract

Defining long-term protective immunity to SARS-CoV-2 is one of the most pressing questions of our time and will require a detailed understanding of potential ways this virus can evolve to escape immune protection. Immune protection will most likely be mediated by antibodies that bind to the viral entry protein, spike (S). Here, we used Phage-DMS, an approach that comprehensively interrogates the effect of all possible mutations on binding to a protein of interest, to define the profile of antibody escape to the SARS-CoV-2 S protein using coronavirus disease 2019 (COVID-19) convalescent plasma. Antibody binding was common in two regions, the fusion peptide and the linker region upstream of the heptad repeat region 2. However, escape mutations were variable within these immunodominant regions. There was also individual variation in less commonly targeted epitopes. This study provides a granular view of potential antibody escape pathways and suggests there will be individual variation in antibody-mediated virus evolution.

Keywords: COVID-19; DMS; SARS-CoV-2; Spike; antibodies; deep mutational scanning; epitope mapping; escape mutations; phage display.
 
Back
Top Bottom